Peptides: New therapies for metabolic diseases?
Christina Rondinone
VP Research and Development, Medimmune
Dr. Rondinone received her Ph.D. in Biochemistry from University of Buenos Aires. Her postdoctoral training was at LCDB, NIDDK, NIH, USA. In 1995, she moved to Sweden where she was appointed Associate Professor , Department of Internal Medicine, University of Gothenburg. From 1998 to 2005, she worked at Abbott Laboratories as a Group Leader. In 2005 she moved to Hoffmann-La Roche where she was Senior Director and Therapeutic Area Head. In 2011 she moved to MedImmune, Inc., as Vice President Research and Development and Head Cardiovascular and Metabolic Diseases, leading the portfolio of biologics in this therapeutic area. She has published more than 65 academic publications and coinventor of 4 patents. She is also member of the Scientific Advisory Board for the Keystone Symposia and she recently was inducted as a member of the Real National Academy of Pharmacy in Spain.